Cargando…
Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
Alzheimer's disease (AD) is a progressive neurological degenerative disease. The main clinical manifestations of AD include progressive cognitive impairment and alteration of personality. Senile plaques, neuroinflammation, and destruction of synapse structure stability are the main pathological...
Autores principales: | Cai, Haobin, Wang, Yijie, He, Jiayang, Cai, Tiantian, Wu, Jun, Fang, Jiansong, Zhang, Rong, Guo, Zhouke, Guan, Li, Zhan, Qinkai, Lin, Li, Xiao, Yao, Pan, Huafeng, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696209/ https://www.ncbi.nlm.nih.gov/pubmed/29190943 http://dx.doi.org/10.18632/oncotarget.21515 |
Ejemplares similares
-
Correction: Neuroprotective effects of bajijiasu against cognitive impairment induced by amyloid-β in APP/PS1 mice
por: Cai, Haobin, et al.
Publicado: (2018) -
Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017) -
Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway
por: Yang, Xin, et al.
Publicado: (2019) -
NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice
por: Tan, Yan, et al.
Publicado: (2022) -
The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer’s Disease
por: Cai, Haobin, et al.
Publicado: (2018)